In two systemic meta-analyses, GLUT1 expression in gallbladder cancer, pancreatic cancer, breast cancer, oral cancer, and lung cancer did correspond to higher tumor grade, lymph node metastasis and larger tumor size, which are all linked to poorer overall survival [29]. Here, SLC2A1 is linked to lung cancer.